{"id":"AGY-FED-HEALTH-OTHER-010","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","eco":"","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA","authority":"21 U.S.C. 829(a); 21 C.F.R. 1306.12(b), 1306.04-.06","instrument":"DEA-DC-017 (DEA065), Dear Registrant letter on early refills and 90-day supplies of controlled substances during the COVID-19 emergency","title":"Early RX Refill (OMB 3-20-20)","dateIssued":"2020-03-20","effective":"2020-03-20","end":"For the duration of the public health emergency","startDate":"2020-03-20","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"addressees":["the general public and the registrant community"],"clause":"pursuant to 21 CFR 1306.12(b) an individual practitioner may issue multiple prescriptions authorizing the patient to receive a total of up to a 90-day supply of a schedule II controlled substance, subject to specific conditions... Subject to the provisions of 21 CFR 1306.06... and if the prescription meets the requirements of 21 CFR 1306.04(a), this practice may be permitted if the early dispensing is allowed by state law and regulation.","enforcement":"Interpretation governing pharmacy dispensing under 21 U.S.C. 829","functions":["CL clinical prescribing","RT pharmacy dispensing","CB patients"],"notes":"Reached pharmacies and prescribers whose patients sought extended supplies under stay-at-home orders.","sourceUrl":"https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-017)(DEA065)%20Early%20RX%20Refill%20-%20OMB%203-20-20%202200%20DAA%20approved.pdf","snapshot":"https://web.archive.org/web/20200323205419/https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-017)(DEA065)%20Early%20RX%20Refill%20-%20OMB%203-20-20%202200%20DAA%20approved.pdf","fileExists":true,"fileBytes":136422,"grade":"primary","character":"","description":"","collection":"AGY-FED-HEALTH-OTHER","url":"/library/AGY-FED-HEALTH-OTHER-010","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-010","citation":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA, DEA-DC-017 (DEA065), Dear Registrant letter on early refills and 90-day supplies of controlled substances during the COVID-19 emergency (Mar. 20, 2020) (Ex. AGY-FED-HEALTH-OTHER-010)","stateName":"","related":["AGY-FED-HEALTH-OTHER-011","AGY-FED-HEALTH-OTHER-014","AGY-FED-HEALTH-OTHER-016","AGY-FED-HEALTH-OTHER-020"]}